Clinical Trials Browser

Azacitidine × Head & Neck × 1 year × Clear all

NCT05317000 2026-01-12

5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT03019003 2025-09-16

Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer Patients

Phase 1 Completed

13 enrolled 12 charts

Head and Neck Neoplasms